Two potential payouts from Johnson & Johnson and Purdue Pharma have provoked varied responses
Efforts to get compensation for the US opioid crisis with two multimillion-dollar drug manufacturer payouts have been met by leading activists and addiction experts with a range of responses from incredulity to cautious optimism.
On Tuesday, the wealthy Sackler family and their embattled drugmaker, Purdue Pharma, makers of two opioids that triggered the crisis, Oxycontin and MSContin, reportedly backed a proposal to resolve all opioid lawsuits against themselves and the company for more than $11bn.
Continue reading...